enGene Holdings Inc

ENGN NYSE Arca Healthcare & Biotech United States
1.76 $
1.71 %

Biotechnology company developing viral vectors for gene therapy, targeting innovative treatments in human and animal health.

Performance & Momentum

6 Months 82.06 %
1 Year 50.31 %
3 Years 85.05 %
5 Years 83.77 %

Similar stocks to enGene Holdings Inc

Anantys Community

Be the first to share your analysis on enGene Holdings Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases